Complex regulation and function of activation-induced cytidine deaminase

Trends in Immunology

Volumn 32, Issue 5, 2011, Pages 194-201

  Stavnezer, Janet ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN;

B LYMPHOCYTE ACTIVATION; CELL TRANSFORMATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; IMMUNOGLOBULIN GENE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SOMATIC HYPERMUTATION;

ANIMALS; B-LYMPHOCYTES; CYTIDINE DEAMINASE; DNA, SUPERHELICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOCYTE ACTIVATION; MICE; RNA STABILITY; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 79955632686     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2011.03.003     Document Type: Review

References (93)

1. Muramatsu M., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
2. Muramatsu M., et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
3. Revy P., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
4. Petersen-Mahrt S.K., et al. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-104.
5. Peled J.U., et al. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 2008, 26:481-511.
6. Guikema J.E., et al. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J. Exp. Med. 2007, 204:3017-3026.
7. Stavnezer J., et al. Mechanism and regulation of class switch recombination. Ann. Rev. Immunol. 2008, 26:261-292.
8. Stavnezer J., et al. Mapping of switch recombination junctions, a tool for studying DNA repair pathways during immunoglobulin class switching. Adv. Immunol. 2010, 108:45-109.
9. Chesi M., et al. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Cancer cell 2008, 13:167-180.
10. Klemm L., et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009, 16:232-245.
11. Okazaki I.M., et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 2003, 197:1173-1181.
12. Morisawa T., et al. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int. J. Cancer 2008, 123:2735-2740.
13. Matsumoto Y., et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 2007, 13:470-476.
14. Storck S., et al. AID and partners: for better and (not) for worse. Curr. Opin. Immunol. 2011, 23:1-8.
15. Chelico L., et al. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2009, 364:583-593.
16. Gurrieri C., et al. Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J. Exp. Med. 2002, 196:629-639.
17. Faili A., et al. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 2002, 3:815-821.
18. Woo C.J., et al. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 2003, 19:479-489.
19. Barreto V., et al. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 2003, 12:501-508.
20. Ta V.T., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 2003, 4:843-848.
21. Shinkura R., et al. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 2004, 5:707-712.
22. Wei M., et al. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat. Immunol. 2011, 12:264-270.
23. Doi T., et al. The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2758-2763.
24. Kracker S., et al. Impaired induction of DNA lesions during immunoglobulin class switch recombination in humans influences end-joining repair. Proc. Nat. Sci. U.S.A. 2010, 107:22225-22230.
25. Boboila C., et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med. 2010, 207:417-427.
26. Yu K., et al. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 2003, 4:442-451.
27. Maul R.W., et al. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat. Immunol. 2011, 12:70-76.
28. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 2007, 76:1-22.
29. Shen H.M., Storb U. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:12997-13002.
30. Collins I., et al. Transcriptional consequences of topoisomerase inhibition. Mol. Cell. Biol. 2001, 21:8437-8451.
31. Basu U., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011, 144:353-363.
32. Schmid M., Jensen T.H. The exosome: a multipurpose RNA-decay machine. Trends Biochem. Sci. 2008, 33:501-510.
33. El Hage A., et al. Loss of topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis. Genes Dev. 2010, 24:1546-1558.
34. Crouch E.E., et al. Regulation of AID expression in the immune response. J. Exp. Med. 2007, 204:1145-1156.
35. Park S.R., et al. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat. Immunol. 2009, 10:540-550.
36. Tran T.H., et al. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol. 2010, 11:148-154.
37. Sherman M.H., et al. AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. Mol. Cell 2010, 39:873-885.
38. Teng G., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28:621-629.
39. Dorsett Y., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28:630-638.
40. Kluiver J., et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007, 26:3769-3776.
41. de Yebenes V.G., et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 2008, 205:2199-2206.
42. Ito S., et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1975-1980.
43. Geisberger R., et al. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6736-6741.
44. Patenaude A.M., et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat. Struct. Mol. Biol. 2009, 16:517-527.
45. Ganesh, K. et al. (2011). CTNNBL1 is a novel NLS-binding protein that recognizes RNA splicing factors CDC5L and PRP31. J. Biol. Chem. (in press), doi:10.1074/jbc.M110.208769.
46. Han L., et al. Cutting edge: CTNNBL1 is dispensable for Ig class switch recombination. J. Immunol. 2010, 185:1379-1381.
47. Maeda K., et al. GANP-mediated recruitment of activation-induced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. J. Biol. Chem. 2010, 285:23945-23953.
48. Aoufouchi S., et al. Proteasomal degradation restricts the nuclear lifespan of AID. J. Exp. Med. 2008, 205:1357-1368.
49. Orthwein A., et al. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. J. Exp. Med. 2010, 207:2751-2765.
50. McBride K.M., et al. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 2008, 205:2585-2594.
51. McBride K.M., et al. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8798-8803.
52. Pasqualucci L., et al. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:395-400.
53. Vuong B.Q., et al. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat. Immunol. 2009, 10:420-426.
54. Chaudhuri J., et al. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 2004, 430:992-998.
55. Cheng H.L., et al. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2717-2722.
56. Gazumyan A., et al. Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol. Cell. Biol. 2011, 31:442-449.
57. Shen H.M., et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998, 280:1750-1752.
58. Pasqualucci L., et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11816-11821.
59. Muschen M., et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 2000, 192:1833-1840.
60. Gordon M.S., et al. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha CD79a). Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4126-4131.
61. Liu M., et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
62. Yamane A., et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 2011, 12:62-69.
63. Staszewski O., et al. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig loci in activated B cells. Mol. Cell 2011, 41:232-242.
64. Berkovich E., et al. Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat. Cell Biol. 2007, 9:683-690.
65. Petersen S., et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001, 414:660-665.
66. Schrader C.E., et al. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J. Immunol. 2007, 179:6064-6071.
67. Rothkamm K., et al. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell Biol. 2003, 23:5706-5715.
68. Mao Z., et al. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle (Georgetown, Tex) 2008, 7:2902-2906.
69. Hasham M.G., et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat. Immunol. 2010, 11:820-826.
70. Pasqualucci L., et al. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 2008, 40:108-112.
71. Robbiani D.F., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
72. Pavri R., et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010, 143:122-133.
73. Nambu Y., et al. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 2003, 302:2137-2140.
74. Peters A., Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 1996, 4:57-65.
75. Rajagopal D., et al. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J. Exp. Med. 2009, 206:1237-1244.
76. Wang L., et al. S region sequence RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination. J. Exp. Med. 2009, 206:1817-1830.
77. Andrulis E.D., et al. The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila. Nature 2002, 420:837-841.
78. Nowak U., et al. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat. Immunol. 2011, 12:160-166.
79. Zannis-Hadjopoulos M., et al. 14-3-3 cruciform-binding proteins as regulators of eukaryotic DNA replication. Trends Biochem. Sci. 2008, 33:44-50.
80. Xu Z., et al. 14-3-3 adaptor proteins recruit AID to 5′-AGCT-3′-rich switch regions for class switch recombination. Nat. Struct. Mol. Biol. 2010, 17:1124-1135.
81. Michael N., et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 2003, 19:235-242.
82. Kothapalli N., et al. Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus. J. Immunol. 2008, 180:2019-2023.
83. Blagodatski A., et al. A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation. PLoS Genet. 2009, 5:e1000332.
84. Kothapalli, N.R., and Fugmann S.D. (2011). Targeting of AID-mediated sequence diversification to immunoglobulin genes. Curr. Opin. Immunol. 23 (in press).
85. Morgan H.D., et al. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 2004, 279:52353-52360.
86. Pauklin S., et al. Estrogen directly activates AID transcription and function. J. Exp. Med. 2009, 206:99-111.
87. Lin C., et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
88. Fritz E.L., Papavasiliou F.N. Cytidine deaminases: AIDing DNA demethylation?. Genes Dev. 2010, 24:2107-2114.
89. Han J.H., et al. Class switch recombination and somatic hypermutation in early mouse B Cells are mediated by B Cell and toll-like receptors. Immunity 2007, 27:64-75.
90. Kuraoka M., et al. AID expression during B-cell development: searching for answers. Immunol. Res. 2011, 49:3-13.
91. Wilson T.M., et al. MSH2-MSH6 stimulates DNA polymerase {eta}, suggesting a role for A:T mutations in antibody genes. J. Exp. Med. 2005, 201:637-645.
92. Genschel J., Modrich P. Mechanism of 5′-directed excision in human mismatch repair. Mol. Cell. 2003, 12:1077-1086.
93. Kadyrov F.A., et al. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 2006, 126:297-308.